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Abstract Barrier characteristics of brain endothelial cells
forming the blood–brain barrier (BBB) are tightly regulated
by cellular and acellular components of the neurovascular
unit. During embryogenesis, the accumulation of the heparan
sulfate proteoglycan agrin in the basement membranes
ensheathing brain vessels correlates with BBB maturation.
In contrast, loss of agrin deposition in the vasculature of brain
tumors is accompanied by the loss of endothelial junctional
proteins. We therefore wondered whether agrin had a direct
effect on the barrier characteristics of brain endothelial cells.
Agrin increased junctional localization of vascular endothelial
(VE)-cadherin, β-catenin, and zonula occludens-1 (ZO-1) but
not of claudin-5 and occludin in the brain endothelioma cell
line bEnd5 without affecting the expression levels of these
proteins. This was accompanied by an agrin-induced reduc-
tion of the paracellular permeability of bEnd5 monolayers. In
vivo, the lack of agrin also led to reduced junctional localiza-
tion of VE-cadherin in brain microvascular endothelial cells.
Taken together, our data support the notion that agrin
contributes to barrier characteristics of brain endothelium by
stabilizing the adherens junction proteins VE-cadherin and β-
catenin and the junctional protein ZO-1 to brain endothelial
junctions.
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Introduction
The blood–brain barrier (BBB) is established at the level of
brain microvessels by highly specialized endothelial cells that
inhibit the free paracellular diffusion of water soluble mole-
cules by an elaborate network of complex tight junctions
(TJs). Combined with the absence of fenestrae and an ex-
tremely low pinocytotic activity, which inhibit the transcellu-
lar passage of molecules across the barrier, these morpholog-
ical features establish the physical permeability barrier of the
BBB (Engelhardt and Sorokin 2009). In addition, a number of
permanently active transport mechanisms expressed at the
level of brain microvascular endothelial cells ensure the
transport of nutrients into the central nervous system (CNS)
and exclusion of toxic metabolites out of the CNS. Thus, the
BBB maintains brain homeostasis, a prerequisite for proper
communication between brain neurons. Moreover, whereas
the endothelial cells constitute the physical and metabolic
barrier per se, barrier characteristics are not an intrinsic feature
of these endothelial cells, but rather rely on the interactions
with adjacent cellular and acellular layers of brain
microvessels (Engelhardt and Sorokin 2009). The fully differ-
entiated BBB consists of the highly specialized endothelial
cells and their underlying endothelial basement membrane, in
which a large number of pericytes are embedded. These
microvessels are surrounded by an ensheathment of astrocytic
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endfeet and their associated parenchymal basement mem-
brane referred to as the glia limitans. As it is now well
established, both pericytes and astrocytes actively contribute,
with their soluble mediators, to the development and mainte-
nance of barrier characteristics in brain microvascular endo-
thelial cells (Engelhardt and Sorokin 2009). In contrast, the
relevance of acellular components, such as the extracellular
matrix (ECM) proteins collagen type IV, various laminin
isoforms, nidogens, or heparan sulfate proteoglycans, to
BBB integrity has not been extensively studied (Engelhardt
and Sorokin 2009). Initial evidence concerning the contribu-
tion of ECM proteins to BBB characteristics has come from
studies showing that endothelial barrier properties increase in
the presence of astrocyte- or pericyte-derived ECM proteins,
and that the enzymatic disruption of ECM proteins decreases
BBB characteristics in vivo (Rosenberg et al. 1993; Hartmann
et al. 2007). Thus, the specific role of individual ECM proteins
in the development or maintenance of barrier characteristics of
brain endothelial cells awaits further studies.
One specific molecule of interest in this context is the
heparan sulfate proteoglycan agrin, which has been found to
accumulate extensively in the basement membrane of the
brain microvasculature (Kroger and Mann 1996). A potential
role for agrin in BBB development is suggested by the obser-
vation that it accumulates around brain microvessels during
chicken and rat embryonic development (Barber and Lieth
1997). In contrast, the loss of agrin expression has been shown
to be correlated with the loss of expression of junctional
proteins in brain vessels of human glioblastoma specimens
or with the enhanced BBB leakiness to blood-borne molecules
in brains of patients with Alzheimer’s disease (Rascher et al.
2002; Berzin et al. 2000), or after global cerebral ischemia
(Baumann et al. 2009) supporting a potential role of agrin in
BBB maintenance.
Agrin is a large extracellular multidomain heparan
sulfate proteoglycan originally isolated from the electric
organ of the marine ray Torpedo californica. It was
identified as organizing the aggregation of skeletal-
muscle-expressed acetylcholine receptors (AChR) be-
neath the nerve terminal (Nitkin et al. 1987). Subse-
quently, agrin was found to be released by motor neurons
from their terminal axons, where it serves as a critical
organizer of postsynaptic differentiation (Gautam et al.
1996). In contrast, little is known about the role of agrin
at sites other than the neuromuscular junction, including
its role in the brain. The high expression level of agrin in
the brain during embryonic development has suggested a
role in the formation of synapses other than those at the
neuromuscular junction. Indeed, evidence has been pre-
sented that agrin plays a role in CNS synapse formation
(Ksiazek et al. 2007). In addition, agrin localization is
observed in all basement membranes of the CNS includ-
ing those of the retina (Kroger and Schroder 2002).
More recent studies have provided evidence for the exis-
tence of multiple, alternatively spliced isoforms of agrin with
various specificities and signaling capabilities (Bezakova and
Ruegg 2003). An alternative first exon can be used at the
amino terminal region to generate agrin isoforms that do not
contain the N-terminal (NtA) domain and are not secreted, but
instead immobilized as type II transmembrane proteins. Two
agrin isoforms containing the laminin-binding NtA domain at
the N-terminus can be distinguished based on the presence or
absence of a seven-amino-acid insertion (Denzer et al. 1995).
The insertion of seven amino acids at this N-terminal splicing
site seems to be specific for the neuronal chicken agrin
(Denzer et al. 1995). In addition, the COOH-terminal region
of agrin splice sites (referred to as A or B in the chicken and y
or z in rodents) accepts peptide inserts of 4 or 8/11/19 amino
acids, respectively (Bezakova and Ruegg 2003). Importantly,
the distinct receptor-binding properties of the agrin isoforms
are attributed to the alternative splicing sites A/y and B/z at the
C-terminus of agrin (Ruegg et al. 1992; Kroger and Schroder
2002). Thus, the secreted neuronal agrin that mediates the
aggregation of postsynaptic proteins displays the insertions
of 7, 4, and 8 amino acids in the A/y and B/z sites and is
referred to as agrin 748. In contrast, amino acid inserts at the
A/y and B/z sites negatively regulate binding of agrin to the
agrin-binding protein α-dystroglycan (α-DG) on astrocytic
endfeet (Scotton et al. 2006). Thus, unsurprisingly, the non-
neuronal agrin isoform without a peptide insert in the A/y and
B/z site (agrin 000) has been reported to be most prominent in
the vascular basement membranes of the CNS (Kroger and
Schroder 2002).
As the role of agrin localized in brain microvascular base-
ment membranes remains unclear, we have asked, in the
present study, whether this heparan sulfate proteoglycan has
a direct impact on the barrier characteristics of brain endothe-
lial cells in vitro and in vivo. The culture of the brain endo-
thelioma cell line bEnd5 on agrin 000 or agrin 748 signifi-
cantly enhances the barrier characteristics of bEnd5 mono-
layers. Decreased permeability of bEnd5 monolayers is ac-
companied by the enhanced localization of vascular endothe-
lial (VE)-cadherin, β-catenin, and zonula occludens (ZO)-1,
but not of the TJ proteins claudin-5 and occludin, in cell-to-
cell junctions of bEnd5. Expression levels of VE-cadherin, β-
catenin, and ZO-1 have been found to be unchanged indicat-
ing that agrin stabilizes these proteins at cell-to-cell junctions
rather than inducing their enhanced expression. To confirm
these in vitro findings, we have analyzed the integrity of the
BBB in agrin-deficient mice, the survival of which is a result
of a muscle-wide expression of a miniaturized form of neural
agrin that rescues focal neuromuscular innervation (c-magB8//
agrn−/−mice; Lin et al. 2008). Indeed, brain microvessels in c-
magB8//agrn
−/− mice that lack agrin in the vascular basement
membranes also show decreased junctional staining for VE-
cadherin. Thus, our data support the notion that the heparan
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sulfate proteoglycan agrin contributes to barrier characteristics
of brain endothelial cells by stabilizing junctional localization




The following primary antibodies were used for immu-
nohistochemistry (IHC) and immunofluorescence (IF)
staining: monoclonal mouse anti-chicken agrin antibodies
5B1 (1:500) and C3 (1:200; Reist et al. 1987), polyclonal
rabbit anti-mouse agrin serum 204 (1:1000; Eusebio
et al. 2003), polyclonal rabbit anti-claudin-5 (1:100;
34–1,600, Zymed), polyclonal rabbit anti-ZO-1 (1:100;
61–7,300, Invitrogen), polyclonal rabbit anti-ZO-1-asso-
ciated Y-box factor (ZONAB, Mid; 1:150; 40–2,800,
Invitrogen), polyclonal rabbit anti-ZO-2 (1:100; 71–
1,400, Zymed), polyclonal rabbit anti-occludin (1:50;
71–1,500, Zymed), polyclonal rabbit anti-β-catenin
(1:2000; C2206, Sigma), monoclonal rat anti-VE-
cadherin (11D4.1, hybridoma supernatant; Gotsch et al.
1997; kindly provided by Prof. Dietmar Vestweber,
Münster, Germany), monoclonal rat anti-JAM-A (BV12;
Bazzoni et al. 2005; kindly provided by Prof. Elisabetta
Dejana, Milan, Italy), polyclonal rabbit anti-laminin
( 1 : 1 0 0 0 f o r I HC , 1 : 4 0 0 0 f o r I F ; Z 0 0 9 7 ,
DakoCytomation), polyclonal rabbit anti-caveolin
(1:450; 610,059, BD Transduction Laboratories), bio-
tinylated polyclonal goat anti-mouse IgG (1:200;
BA9200, Vector). The following isotype controls were
applied: normal rabbit IgG (AB-105-C, R&D Systems),
purified mouse IgG1 (400,101, Biolegend), normal rabbit
serum (C125B, Serotec), monoclonal rat anti-human
CD44 (9B5, hybridoma supernatant), and purified rat
IgG2a (553,927, Pharmingen).
For IF staining, the secondary antibodies DyLight-488-
conjugated Streptavidin (1:500; 016-480-084, Jackson),
Alexa-Fluor-488 polyclonal goat anti-rabbit IgG heavy and
light (H+L), polyclonal goat anti-rat IgG H+L (1:200; Mo-
lecular Probes, Invitrogen), AMCA-conjugated AffiniPure F
(ab’) 2 fragment goat anti-rabbit IgG H+L (1:100; Jackson,
ImmunoResearch), Cy3-conjugated AffiniPure polyclonal
goat anti-rat IgG H+L, goat anti-rabbit IgG H+L, and poly-
clonal donkey anti-mouse IgG H+L (1:200; Jackson,
ImmunoResearch) were employed.
For IHC, secondary biotinylated polyclonal goat anti-
rabbit IgG and anti-rat IgG antibodies from the
Vectastain ABC kits (Vector PK 6104 and PK 6101)
were used for primary antibody detection.
Cells
Human embryonic kidney (HEK) cells expressing the secret-
ed non-neuronal chicken agrin A0A0B0 (agrin 000) or the
secreted neuronal chicken agrin A7A4B8 (agrin 748) iso-
forms and their culture conditions were as previously de-
scribed in detail and were used unchanged in the present study
(Kroger 1997). HEK cells were seeded on laminin (from
Engelbreth-Holm-Swarm sarcoma, Roche), and after 7 days
of culture expression, the secretion and deposition of agrin on
laminin was analyzed by IF staining of the HEK cells before
or after lysis with 0.3 % (v/v) Triton X-100 (Fluka) in
phosphate-buffered saline (PBS) or by Western blot analysis.
The polyoma middle T oncogen transformed mouse brain
endothelioma cell line bEnd5 was established by Werner
Risau, with its endothelial characteristics, including high pu-
rity and contact-inhibition, described in great detail by Reiss
et al. (1998). More recently, we have provided a more detailed
analysis of bEnd5 as an in vitro BBB model (Paolinelli et al.
2013; Steiner et al. 2011).
The isolation, culture, and characterization of primary
mouse brain microvascular endothelial cells (pMBMECs)
were performed exactly as previously described in detail
(Coisne et al. 2005). We and others have described the char-
acteristics of pMBMEC cultures and consider them to be
excellent in vitro BBB models of high endothelial purity
forming monolayers that establish a tight permeability barrier
(Coisne et al. 2005, 2006; Steiner et al. 2011). Exactly as
described before, pMBMECs were cultured on Matrigel con-
taining a mixture of ECMproteins (mostly laminins) extracted
from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma
tumor. To verify the lack of agrin in the Matrigel matrix, we
performed Western blot and IF staining of the matrix.
Mice
The chicken mini-agrin transgenic (c-magB8), agrin-deficient
(agrn−/−) mice have been previously described (Lin et al.
2008) and are referred to as c-magB8//agrn
−/− mice or rescued
agrin knock-out mice below. The transgenic animals express
the gene for the chicken mini-agrin, consisting of the
25 kDa N-terminal and 21 kDa C-terminal fragment of the
secreted full-length neuronal chicken agrin protein, which
include the laminin-binding and acetylcholine-receptor-
aggregating domains, respectively, under the muscle creatine
kinase (MCK) promoter to restore neuromuscular junction
formation and to prevent perinatal death (Moll et al. 2001).
All animal procedures were performed in accordance with
Swiss legislation concerning the protection of animals and
were approved by the Amt für Landwirtschaft und Natur,
Veterinärdienst, Sekretariat Tierversuche (Department for Ag-
riculture and Nature, Veterinary Service, Registry for Animal
Experimentation) of the Kanton Bern.
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IF staining of brain endothelial cells
IF staining was performed exactly as described previously
(Steiner et al. 2011) and was analyzed by using a Nikon
Eclipse E600 microscope equipped with a digital camera.
Images were further processed with NIS Elements software.
To analyze the gray values of the junction-associated IF sig-
nal, ImageJ software 1.42q was used. To this end, random
lines were drawn over a micrograph of the cell monolayer at
original magnification, and the measured peaks of the gray
values clearly associated with the cell-cell junctions were
noted (Supplementary Fig. 1). For the calculation of the mean
gray value per image, 8 gray values of cell-cell junctions
randomly distributed over the entire micrograph were selected
in a blinded manner. This procedure was repeated for 5 images
per condition for each single experiment. The gray value
means of each single experiment, representing 40 measured
gray values of cell-cell junctions per condition, are represent-
ed in the figures below by a symbol and a line, the latter
showing the mean values of all experiments performed.
Lipid raft staining was performed with the cholera toxin
subunit B (CTx-B) conjugated to Alexa-Fluor-488 (1:100;
C-34775, Molecular Probes) for 1 h at room temperature,
followed by fixation in 1 % (w/v) paraformaldehyde in PBS
(PFA/PBS) for 10 min at room temperature, staining of the
cell nuclei with 4′6-diamidino-5-phenylindole (DAPI;
Applichem), and mounting of the specimens in Mowiol
(Calbiochem).
IF/IHC staining of tissue sections
IF and IHC staining of mouse brain tissue sections was per-
formed exactly as described by our group previously (Deutsch
et al. 2008). The sections were analyzed by using a Nikon
Eclipse E600 microscope equipped with a digital camera.
Images were further processed with NIS Elements software.
For optical sectioning and three-dimensional (3D) reconstruc-
tion, 10-μm-thick cryosections were stained as described pre-
viously, and 10 stacks/vessel every 400 nm were
photographed via an AxioObserver Z1 microscope equipped
with an ApoTome and a monochrome charge-coupled device
camera (Carl Zeiss, Switzerland).The sections were further
analyzed with AxioVision (Carl Zeiss) software.
Fluorescence-activated cell sorting analysis of bEnd5 cells
Fluorescence-activated cell sorting (FACS) analysis for cell
surface proteins of bEnd5 cells was performed exactly as
described previously (Engelhardt et al. 1997; Reiss et al.
1998). Cell surface expression of VE-cadherin was deter-
mined by using the rat-anti-mouse monoclonal antibodies
11D4 and BV13. Data were analyzed by using BD
FACSCalibur and FlowJo Software (TreeStar).
Gel electrophoresis and Western blot
Brain endothelial cells were washed three times with ice-cold
PBS, scratched off the culture dish surface, and harvested in
2× sample buffer (Laemmli Buffer, 200 mM dithiothreitole).
The samples were heated for 3 min at 95 °C, separated on a
polyacrylamide gel, and blotted onto nitrocellulose (Whatman
Protran transfer membrane, 0.2μM pore size). To analyze the
protein content of the brain, one cerebral hemisphere per
animal was homogenized in 10 volumes (w/v) of ice-cold
RIPA buffer (50 mM TRIS pH 7.5, 150 mM NaCl, 0.5 %
Na-deoxycholate, 0.1 % SDS, 1 % NP-40) containing prote-
ase inhibitors (Complete Mini EDTA free protease inhibitor
cocktail tablets, Roche). After a 5-min centrifugation step at
3000g, the supernatant was collected, and the protein concen-
tration was determined with a BCA protein assay kit
(Pierce). Of the total protein per sample, 30 μg was mixed
with 2× sample buffer, heated for 3 min at 95 °C, and loaded
onto a polyacrylamide gel. After the blocking of the nitrocel-
lulose membrane in PBS/2 % (w/v) bovine serum albumin
(fraction V, Applichem) or PBS/5 % milk for 20 min at room
temperature, the membrane was incubated with the following
primary antibodies overnight at 4 °C: mouse anti-β-actin
antibody (1:1000; A5316, Sigma), rabbit anti-ZO-1 (1:1000;
61–7,300, Invitrogen), rat anti-VE-cadherin (3 μg/ml;
11D4.1, purified), rabbit anti-β-catenin (1:1000; C2206, Sig-
ma). After being washed with PBS, the primary antibodies
were detected by goat anti-mouse or anti-rat IRDye 680 or
goat anti-mouse or anti-rabbit IRDye 800CW (LI-COR Bio-
sciences), and the membrane was scanned with the Odyssey
Infrared imaging system. The intensities of the protein bands
analyzed were always normalized to the corresponding β-
actin band intensities.
Quantitative reverse transcription plus the polymerase chain
reaction
Quantitative real-time reverse transcription plus the polymer-
ase chain reaction (RT-PCR; of 1 ng cDNA per reaction in
triplicate) was performed exactly as previously described
(Lyck et al. 2009). In brief, cellular RNAwas extracted from
bEnd5 after 24 h in culture with the RNAready kit
(BioDiagnostik) according to the manufacturer’s protocol.
cDNA was synthesized from 60-80 ng RNA by using the
SuperScript First-Strand Synthesis System for RT-PCR
(Invitrogen) with random hexamers. Control cDNAwas gen-
erated without adding reverse transcriptase. Expression of the
genes of interest was analyzed after 40 cycles by using the
MESA GREEN qPCR MasterMix Plus for SYBR Assay I
Low Rox and the Fast Real-Time PCR System 7,500 or the
ViiA7 RT-PCR System (Applied Biosystems). Relative ex-
pression values were calculated according to the comparative
ΔCTmethod (RQ = relative expression = 2-ΔCT, ΔCT = average
468 Cell Tissue Res (2014) 358:465–479
CT value of target gene-average CT value of endogenous refer-
ence gene). s16 ribosomal protein mRNA served as endoge-
nous control. The following primer pairs were used: target ZO-
1: sense tggtgaagtctcggaaaaatg; reverse tgctgccaaactatcttgtga;
target VE-cadherin: sense gttcaagtttgccctgaagaa; reverse
g t g a t g t t g g c gg t g t t g t ; t a r g e t β - c a t e n i n : s e n s e
gcagcagcagtttgtggag; reverse tgtggagagctccagtacacc; s16r
p r o t e i n : s e n s e g a t a t t c g g g t c c g t g t g a ; r e v e r s e
ttgagatggactgtcggatg. The primers were designed to obtain a
PCR product at around 80 nucleotides. The CT values for target
and reference genes were always below 29 cycles.
Proliferation assay
The proliferative activity of the cells was measured by the
addition of 1μCi per well 3H-thymidine (Amersham, UK) for
the last 16 h of culture, and incorporated 3H-thymidine was
detected with a Liquid Scintillation Counter (LS 5000CE,
Beckman).
Annexin V/propidium iodide staining
Cellular apoptosis and necrosis was determined by staining
for Annexin V and propidium iodide (PI) and subsequent
measurement by flow cytometry on a FACSCalibur and anal-
ysis with FlowJo Version 9.1 software.
In vivo BBB permeability assay
Eleven c-magB8//agrn
−/− mice and nine respective con-
trols (4c-magB8//agrn
+/− and 5 c-magB8//agrn
+/+) were
injected intravenously with 1000 μg/animal Cascade blue
3-kDa Dextran (Molecular Probes) and 1000 μg/animal
fluorescein isothiocyanate (FITC) 10-kDa Dextran (Mo-
lecular Probes). After 15 min, mice were anesthetized
with Isoflurane (Baxter) and perfused with 10 ml cold
PBS followed by fixation in 10 ml 4 % (w/v) PFA/PBS.
Brains and kidneys were removed and snap-frozen in
Tissue-TEK (OCT compound, Sysmex Digitana) on dry
ice/2-methylbutane (Grogg Chemie). The tissue was
stored at −80 °C, and 6-μm-thick cryosections were
mounted on Superfrost Plus (Menzel) slides, air-dried,
and fixed with 1 % (w/v) PFA/PBS for 10 min at room
temperature. The sections were stained according to the
protocol for the IF staining of organ sections and were
directly analyzed under the microscope.
Statistical analysis
Statistical significance was analyzed with Prism Version
4.01, employing the unpaired t-test or Wilcoxon signed
rank test. P<0.05 was considered as being statistically
significant.
Results
Agrin reduced the permeability of bEnd5 monolayers
We have previously shown that, in contrast to pMBMECs,
the mouse brain endothelioma cell line bEnd5 fails to
establish a tight diffusion barrier in vitro (Steiner et al.
2011). Therefore, we first asked whether barrier character-
istics of bEnd5 can be improved by growing the cells in the
presence of exogenous agrin. As a source for exogenous
agrin, we used HEK cells expressing the secreted non-
neuronal (agrin 000) or neuronal (agrin 748) chicken agrin
isoforms, both containing the laminin-binding NtA domain
(Denzer et al. 1995). Non-transfected HEK cells were used
to produce control ECM. HEK cells were cultured on lam-
inin, and expression of agrin was detected by IF staining of
confluent HEK monolayers at 6–7 days in culture (Supple-
mentary Fig. 2A). The lysis of the HEK cells and subse-
quent IF staining for agrin detected secreted agrin bound to
the laminin matrix (Supplementary Fig. 2B). Additionally,
bEnd5 cells were found to express endogenous mouse
agrin. Intracellular expression of agrin could be detected
in bEnd5 starting at 48 h in culture, whereas deposition of
significant amounts of agrin on laminin was only visible
after 7 days in culture (Supplementary Fig. 3). To determine
whether exogenous agrin influenced barrier characteristics
of bEnd5 monolayers, assays were therefore always per-
formed, at the latest, after 48 h of culture. The culturing of
bEnd5 cells for 48 h on chicken agrin 000 or agrin 748
resulted in the reduced permeability of bEnd5 monolayers
to 3-kDa Dextran when compared with bEnd5 grown on the
matrix of control HEK cells. The permeability coefficient
(Pe) of bEnd5 for 3-kDa Dextran of 3.8 ×10−3 cm/min was
reduced to 2.7 ×10−3 cm/min on agrin 000 and to 3.1
×10−3 cm/min on agrin 748 (Fig. 1). Thus, the laminin
bound exogenously provided agrin isoforms 000 and 748
could both reduce the paracellular permeability of bEnd5
cell monolayers in vitro.
Agrin increased junctional staining for VE-cadherin,
β-catenin, and ZO-1 in bEnd5 cells
Agrin-mediated reduction of paracellular permeability of
bEnd5 suggested to us an improved junctional architecture
of bEnd5. We therefore investigated the cellular localization
of several adherens (AJ) and tight (TJ) junction-associated
proteins in bEnd5 cells by IF staining. bEnd5 cells grown on
control matrix showed the junctional localization of the AJ
transmembrane protein VE-cadherin, the AJ-associated cyto-
plasmic proteins β-catenin and γ-catenin (data not shown),
the TJ transmembrane proteins claudin-5 and occludin, and
the cytoplasmic scaffolding proteins ZO-1 and ZO-2 (Fig. 2,
Supplementary Fig. 4, Supplementary Fig. 5). When bEnd5
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cells were grown on agrin 000 or agrin 748, the junctional IF
signals for VE-cadherin, β-catenin, and ZO-1 increased when
compared with those in bEnd5 cells grown under control
conditions (Fig. 2, Supplementary Fig. 4). In contrast, junc-
tional IF staining for claudin-5, occludin, and ZO-2 remained
unchanged in bEnd5 cells grown in the presence of agrin
(Supplementary Fig. 5). Furthermore, the IF signal of the
ZO-1-associated nucleic-acid-binding protein ZONAB,
which promotes cellular proliferation via accumulation in
the cell nucleus, was also not affected (Fig. 2, Supplementary
Fig. 4; Balda et al. 2003). An additional nuclear IF-staining
signal was detected for ZONAB and ZO-1 in bEnd5 cells
grown on agrin and control matrix thereby supporting their
role in brain endothelial cell proliferation and gene expres-
sion (Balda and Matter 2009). Finally, we could not detect
any signs of F-actin cytoskeletal rearrangement in bEnd5
cells grown on agrin compared with control conditions
(Fig. 2). To quantify the microscopically observed changes
in junctional IF signals, we performed a computer-assisted
measurement of the gray values for the respective IF
staining at the cellular junctions (Fig. 2, Supplementary
Fig. 1). These analyses showed 18–27 % increased junc-
tional gray values for IF staining for VE-cadherin, β-
catenin, and ZO-1, when bEnd5 cells were cultured on
agrin 000 and agrin 748 as compared with control
(Fig. 2). In contrast, the quantification of junctional gray
values of the IF signals for ZONAB (Fig. 2), claudin-5,
occludin, and ZO-2 (Supplementary Fig. 5) did not reveal
any differences thereby confirming the visual microscopic
analysis. Thus, bEnd5 cells grown on agrin 000 and agrin
784 showed increased junctional IF staining for VE-
cadherin, β-catenin, and ZO-1.
Agrin stabilizes VE-cadherin, β-catenin, and ZO-1 in bEnd5
cellular junctions
To test whether the increased junctional IF staining for VE-
cadherin, β-catenin, and ZO-1 in bEnd5 cells grown on agrin
was attributable to the increased expression of these proteins,
we performed RT-PCR and Western blot analyses (Fig. 3). As
increased junctional IF staining for these proteins was detect-
ed after 48 h of culture of bEnd5 cells on agrin, mRNAwas
isolated from bEnd5 after 24 h in culture, and total protein of
bEnd5 cells was collected after 48 h of culture. mRNA levels
for VE-cadherin, β-catenin, and ZO-1 were found to be un-
changed in bEnd5 cells grown on agrin 000 or agrin 748
compared with bEnd5 grown on control matrix showing that
the transcriptional regulation of VE-cadherin, β-catenin, and
ZO-1 in bEnd5 cells is not influenced by the presence of
extracellular agrin (Fig. 3). When analyzing total protein
levels for these junctional molecules by Western blot, we
detected no difference in the amount of VE-cadherin or β-
catenin in bEnd5 cells grown in the presence or absence of
agrin (Fig. 3b, d). Similarly, cell surface expression of VE-
cadherin as determined by FACS analysis was found to be
unaltered (Supplementary Fig. 6). In light of the recent
observation that E-cadherin molecules can also be local-
ized in the contact-free plasma membrane throughout the
epithelial cell (Borghi et al. 2012), these observations
suggest that agrin leads to the redistribution of VE-
cadherin from contact-free plasma membrane domains
into the cell-cell contacts of bEnd5. In contrast, bEnd5
cells, especially when grown on agrin 000 but also on
agrin 784, showed significantly increased levels of ZO-1
protein (Fig. 3f). Taken together, these data enable us to
conclude that extracellular agrin leads to a difference in
the cellular distribution of VE-cadherin, β-catenin, and
ZO-1 leading to their accumulation in endothelial junc-
tions of bEnd5 cells. The results also suggest that the
presence of extracellular agrin stabilizes the localization
of ZO-1, β-catenin, and VE-cadherin in this cellular
Fig. 1 Agrin 000 and agrin 748 reduce permeability of bEnd5 mono-
layers. The bEnd5 cells were cultured in the presence or absence of
chicken agrin 000 or agrin 748, and the permeability to 3-kDa Dextran
was measured after 48 h in culture. Bars represent the mean permeability
coefficient (Pe) values of five independent experiments, each performed
in triplicate (± SEM). *P<0.05
Fig. 2 Agrin 000 and agrin 748 increase junctional localization of
vascular endothelial cadherin (VE-cadherin), β-catenin, and zonula
occludens-1 (ZO-1) in bEnd5 cells. Immunofluorescence (IF) staining
was performed after the culturing of bEnd5 cells for 48 h in the absence or
presence of chicken agrin 000 or agrin 748. Cells were stained for VE-
cadherin (a, a’, a’’), β-catenin (b, b’ b’’), ZO-1 (c, c’, c’’), ZO-1-
associated Y-box factor (ZONAB; d, d’, d’’), and F-actin (e, e’, e’’).
Representative micrographs from 4–5 independent experiments. Bar
50 μm. To quantify the IF signal at the junctions, the gray values of the
VE-cadherin (f),β-catenin (g), ZO-1 (h), and ZONAB (i) IF signals at the
bEnd5 junctions were measured with ImageJ software. Symbols represent
the mean values of each independent experiment (f, g, n=5; h, n=6; i, n=
4); the means over all experiments is represented by the horizontal lines.
Gray values were normalized to the control condition for every
independent experiment (n.s. not significant)
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compartment, an event that in the case of ZO-1, seems to
be accompanied by an increase in the half-life of the
protein in bEnd5.
Agrin reduces bEnd5 cell proliferation
Increased accumulation of β-catenin at the cell-cell junctions
of bEnd5 cells grown on agrin protein might eventually limit
its translocation to the nucleus, where it can act as a transcrip-
tion factor and upregulate the transcription of cyclin D1 and
MYC (Dejana 2004). Inhibition of this activity would indi-
rectly limit the growth of bEnd5 cells. We therefore asked
whether bEnd5 cells grown on agrin showed a different cel-
lular proliferation rate when compared with bEnd5 grown in
the absence of exogenous agrin. To this end, we measured the
proliferation of bEnd5 by analyzing 3H-thymidine incorpora-
tion into DNA of bEnd5 cells grown on agrin 000, agrin 748,
or under control conditions (Fig. 4) and observed a signifi-
cantly reduced uptake of 3H-thymidine, when bEnd5 cells
were cultured in the presence of agrin 000 or agrin 748
(Fig. 4). Additional direct counting of bEnd5 cells after 48 h
in culture showed a significantly reduced expansion of cell
numbers of bEnd5 cells grown on agrin (Fig. 4). To rule out
the possibility that reduced bEnd5 cell numbers were attribut-
able to agrin-induced cell death, we performed FACS staining
for Annexin Vand PI. We could see that agrin neither induced
apoptosis (Ann+ PI−) nor necrosis (PI+) of bEnd5 cells under
the applied culture conditions (Fig. 4). These data suggested
that agrin limited the growth of bEnd5.
Agrin−/− pMBMECs show reduced junctional localization
of VE-cadherin, β-catenin, and ZO-1
To further determine the role of agrin in stabilizing VE-
cadherin, β-catenin and ZO-1 in brain endothelial junctions,
we next asked whether the complete absence of agrin expres-
sion in brain endothelial cells disturbed the junctional locali-
zation of those molecules. To this end, we isolated pMBMECs
from agrin−/− mice that expressed a chicken mini-agrin trans-
gene under the muscle creatine kinase promoter (c-magB8//
Fig. 3 Agrin 000 and agrin 748
do not increase expression levels
of VE-cadherin, β-catenin and
ZO-1 in bEnd5 cells. a, c, e
Quantitative reverse transcription
plus the polymerase chain
reaction was performed to
analyze VE-cadherin, β-catenin,
and ZO-1 mRNA levels in bEnd5
cells cultured for 24 h on agrin
000, agrin 748, or under control
conditions. Relative expression
(RQ) values were normalized to
the control condition for every
independent experiment. Bars
represent the mean of three
independent experiments (±
SEM). s16 ribosomal protein
mRNA served as endogenous
control. b, d, f bEnd5 total VE-
cadherin, β-catenin, and ZO-1
protein amounts were determined
byWestern blot analysis after 48 h
in culture. Protein levels were
normalized to the endogenous
control protein β-actin. Values
were normalized to the control
condition for every independent
experiment. Bars represent the
mean of three (VE-cadherin, β-
catenin) and six (ZO-1)
independent experiments (±
SEM). *P<0.05 (n.s. not
significant)
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agrn−/−; Lin et al. 2008) and from transgenic control litter-
mates (c-magB8//agrn
+/+). Immunostaining for agrin confirmed
positive staining on pMBMECs isolated from c-magB8//agrn
+/+
mice and an absence of agrin immunostaining on pMBMECs
of c-magB8//agrn
−/− mice as expected (Fig. 5). Interestingly,
agrin−/− pMBMECs showed reduced junctional IF staining of
VE-cadherin, β-catenin, and ZO-1 (Fig. 5, Supplementa-
ry Fig. 7) confirming a role for agrin in stabilizing the
junctional localization of those proteins. The additional
nuclear IF staining signal detected for ZO-1 and β-
catenin in pMBMECs from both c-magB8//agrn
+/+ and
c-magB8//agrn
−/− mice, supporting their role in brain en-
dothelial cell proliferation and gene expression (Balda
and Matter 2009; Liebner and Plate 2010), remained
unchanged. However, agrin−/− pMBMECs grown to
confluency over 7 days did not show an increased per-
meability for 3-kDa Dextran when compared with
agrin+/+ pMBMECs (Fig. 5). This suggests that compen-
satory mechanisms, e.g., the complex and continuous TJs
established by pMBMECs, can overcome the lack of
agrin and the accompanying reduced integrity of AJ in
pMBMECs to stabilize barrier characteristics in vitro.
Agrin stabilizes junctional localization of VE-cadherin
in brain microvascular endothelial cells in vivo
To determine definitively whether the absence of agrin was
correlated with reduced junctional localization of AJ molecules
in brain vessels in vivo, we investigated whether the junctional
localization of VE-cadherin was altered in c-magB8//agrn
−/−
mice. IF staining, followed by optical sectioning and 3D recon-
struction of the endothelial VE-cadherin signal, produced a more
diffuse and less circumscribed junctional staining pattern in brain
microvessels of c-magB8//agrn
−/− mice, when compared with
those of heterozygous control mice (c-magB8//agrn
+/−; Fig. 6).
Therefore, our in vivo data further supported the notion that
extracellular agrin maintained the integrity of AJs by stabilizing
the junctional localization of VE-cadherin. To assess whether the
impaired integrity of AJs translated into impaired barrier charac-
teristics of the BBB in vivo, we analyzed the leakage of endog-
enous immunoglobulin, fibrinogen, and fibronectin and of exog-
enous 3-kDa Cascade blue and 10-kDa FITC-Dextran across the
BBB in female and male c-magB8//agrn
−/− mice and c-magB8//
agrn+/+ control littermates by IF staining and the analysis of brain
cryosections. In brain sections of 7 out of 23 c-magB8//agrn
−/−
Fig. 4 Agrin 000 and agrin 748 reduce the proliferation rate of bEnd5
cells. a Cellular proliferation was measured by 3H-thymidine uptake after
48 h in culture (CPM counts per minute). The values of each experiment
were normalized to the respective control condition. Bars represent the
mean of six independent experiments (± SEM). *P<0.05. b bEnd5 cells
were counted after 48 h in culture in the presence of agrin 000, agrin 748,
or under control conditions. Symbols represent the triplicates of one
experiment, and the mean (horizontal line) is shown for better visualiza-
tion. c After 48 h, the percentage of apoptotic and necrotic cells was
analyzed by Annexin V (Ann) and propidium iodide (PI) staining. Pos-
itive bEnd5 cells were analyzed by flow cytometry. Symbols represent
values of two independent experiments, and the horizontal lines represent
the means
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mice (age 11–21weeks, females andmales) we found a subset of
brain microvessels with deposition of endogenous plasma pro-
teins beyond the laminin positive vascular basement membranes
of brain microvessels suggesting focal impairment of the BBB in
thesemice (Table 1). In brain sections of 3 out of this group of 23
c-magB8//agrn
−/− mice we found a subset of brain microvessels
with diffusion of intravenously infused 3kDA Cascade blue or
10kDA FITC-dextran, respectively, beyond the laminin positive
vascular basement membranes of brainmicrovessels furthermore
underlining focal impairment of the BBB in thesemice (Table 1).
Combining both methods, we could not determine a correlation
of BBB leakiness with age or gender of the mice. Leaky brain
microvessels preferentially localized to the cortex, hippocampus,
or cerebellum. BBB leakiness was, however, not observed in the
remaining 16 c-magB8//agrn
−/− mice investigated (Table 1) and
was also absent in seven age-matched c-magB8//agrn
+/+ control
mice. The focal nature of the BBB impairment observed in c-
magB8//agrn
−/−mice, together with the finding that only 29 % of
c-magB8//agrn
−/−mice showed any signs of focal BBB leakiness,
suggests that the lack of agrin in the vascular basement mem-
brane and the resulting impaired AJ integrity do not suffice to
impair BBB function. Rather, as previously observed in vitro,
compensatory mechanisms, e.g., the unique and complex TJs of
the BBB, seem to stabilize the barrier characteristics of the brain
microvessels in vivo, and the focal failure of the BBB in a subset
of c-magB8//agrn
−/− mice might depend on additional
pathomechanisms in these rescued agrin knock-out mice.
Discussion
In the present study, we show that the heparan sulfate proteo-
glycan agrin stabilizes the junctional localization of the AJ
proteins VE-cadherin, β-catenin, and ZO-1 in brain endothe-
lial cells in vitro and in vivo without affecting their expression
levels in brain endothelial cells. Whereas exogenous agrin
reduces the paracellular permeability of brain endothelial cells
in vitro, the lack of agrin in primary brain microvascular
endothelial cells in vitro and in c-magB8//agrn
−/− mice
in vivo does not show decreased barrier characteristics. Our
observations therefore indicate a novel role of agrin in directly
or indirectly stabilizing brain endothelial AJs and thus brain
vascular integrity. A potential role for agrin in maintaining
BBB characteristics has previously been suggested by Noell
et al. (2009); however, their studies focused on the activity of
agrin on astrocytes and demonstrated that agrin ensured as-
trocyte polarity by binding to the astrocyte foot-process an-
choring molecule dystroglycan. As we have previously ob-
served agrin immunoreactivity in the endothelial and paren-
chymal basement membranes of brain microvessels
(Wolburg-Buchholz et al. 2009), our aim here has been to
determine whether agrin might also exert direct effects on
brain endothelial characteristics.
Anticipating potential differences in the biological activi-
ties of the secreted agrin isoforms, we cultured bEnd5 cells on
both the neuronal (agrin 748) and the non-neuronal (agrin
000) agrin isoforms, which display distinct receptor binding
properties because of their alternatively spliced exons coding
for isoforms that are different at the C-terminus (Ruegg et al.
1992; Kroger and Schroder 2002).Whereas the neuronal agrin
protein is known to bind to LRP4 (Zhang et al. 2008), the non-
neuronal agrin isoform binds to α-dystroglycan with high
affinity (Meier et al. 1996; Scotton et al. 2006). To our
surprise, we could not detect any significant differences be-
tween agrin 000 and agrin 748 in enhancing the barrier char-
acteristics of bEnd5 cells. Thus, the endothelial binding do-
mains of agrin and the endothelial ligands for agrin remain to
be defined. Possible candidate molecules are endothelial
integrins, such as αV-integrin, which has previously been
shown to interact with agrin (Martin and Sanes 1997). Alter-
natively, the glycosaminoglycan side-chains of the heparan
sulfate proteoglycan agrin (Winzen et al. 2003) might play a
role in the agrin-induced barrier characteristics of brain endo-
thelial cells.
In the present study, we could correlate the agrin-induced
reduction of paracellular permeability of bEnd5 to the in-
creased localization of the AJ proteins VE-cadherin and β-
catenin and of the scaffolding protein ZO-1 to endothelial cell
junctions. Localization of the transmembrane VE-cadherin to
endothelial AJs has been reported to be a prerequisite for
vascular integrity and junctional maturation of the endothelial
cells in peripheral vascular beds (Dejana et al. 2009). The
extracellular domains of VE-cadherin establish homophilic
adhesive interactions between adjacent endothelial cells. Sta-
bilization of the AJ is achieved by anchoring VE-cadherin to
the actin cytoskeleton via its interaction with p120, β-catenin,
Fig. 5 Agrin−/− pMBMECs show reduced junctional localization of VE-
cadherin, β-catenin, and ZO-1. a, b Primary mouse brain microvascular
endothelial cells (pMBMECs) were isolated from rescued agrin knock-out
(c-magB8//agrn
−/−) or control littermates (c-magB8//agrn
+/+), and after
7 days in culture, immunofluorescence staining for agrin was performed.
The presence of the extracellular matrix protein agrin is visible by specific
binding of the fluorochrome-labeled anti-agrin antibody in control cells
(white signal in b), and the absence of this binding on agrin-knock-out
endothelial cells (no fluorescence signal in a). Micrographs from one
representative experiment out of five are shown. Bar 50 μm. c
Permeability of agrin-deficient (c-magB8//agrn
−/−) and control
pMBMECs (c-magB8//agrn
+/+) was measured after 7 days in culture for
3-kDa Dextran. Bars represent the mean of seven independent experiments
(± SEM). d–iAfter 7 days, pMBMECs isolated from rescued agrin knock-
out (c-magB8//agrn
−/−) or control littermates (c-magB8//agrn
+/+) were
stained for VE-cadherin (d, e), β-catenin (g, h), and ZO-1 (j, k), and the
junctional IF signal quantified bymeasuring the gray values at the junctions
(f, i, l). Micrographs of one representative experiment out of five are
shown. Bars 50 μm. The gray values of the knock-out cells were
normalized to value of the control cells, which was set to 1. Each symbol
represents the mean gray value of all five independent experiments, and the
horizontal lines indicate the means of all experiments performed. *P<0.05
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andα-catenin. The important role forβ-catenin in AJ integrity
is underlined by the observation that β-catenin-deficient en-
dothelial cells show disorganized AJs and increased
paracellular permeability (Cattelino et al. 2003). In addition
to the increased junctional localization of the AJ proteins VE-
cadherin andβ-catenin, agrin also increases the localization of
ZO-1 to cell-cell junctions. ZO-1 is a member of the ZO
scaffolding protein family, which bind via N-terminal pro-
tein-binding domains to transmembrane TJ proteins and via
their C-terminus directly to F-actin or other actin-binding
proteins (Fanning and Anderson 2009). Combined with the
observation that agrin does not influence the cellular
distribution of the TJ proteins claudin-5, occludin, and ZO-
2, the agrin-induced increased junctional localization of ZO-1
might instead be attributable to its accumulation in AJs. Pre-
vious studies have suggested that ZO-1 not only localizes to
TJs but can also be present in AJs, most probably via binding
to α-catenin (Ikenouchi et al. 2007). The finding that the
increased junctional detection of VE-cadherin, β-catenin,
and ZO-1 induced by agrin is not accompanied by the in-
creased transcription of these proteins or by the altered cell
surface expression levels of VE-cadherin in brain endothelial
cells leads us to suggest that agrin instead stabilizes the
junctional localization of these proteins. This is further
Fig. 6 Agrin stabilizes junctional
localization of VE-cadherin in
brain microvascular endothelial
cells in vivo. Three-dimensional
reconstruction of VE-cadherin
(red)-immunostained brain
vessels. In each column, vessels
from three different mice are
shown. In c-magB8//agrn
−/− mice
(b, d, f), VE-cadherin
immunostaining is more diffuse
and does not display a clear
junctional staining pattern
compared with the staining
observed in vessels of
heterozygous control animals (c-
magB8//agrn
+/−; a, c, e). Indicated
numbers represent the length of
the white bar in micrometers.
Representative micrographs of
three animals out of four agrin
knockout and four control
animals are shown
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supported by our observation that the junctional localization
of VE-cadherin, β-catenin, and ZO-1 is reduced in primary
brain endothelial cells deficient for agrin compared with wild-
type brain endothelial cells. Confirming previous observations
in mice lacking vascular agrin (Rauch et al. 2011), agrin in our
present study fails to influence the junctional localization of
the TJ proteins claudin-5, occludin, and ZO-2.
In addition to mediating junctional stability, cadherins and
their cytoplasmic binding partners are known to be involved
in cellular signaling mechanisms. Stabilization of β-catenin in
brain endothelial cells has been shown to enhance the matu-
ration of the BBB via the canonical Wnt signaling pathway
(Liebner et al. 2008). Cadherins regulate the Wnt signaling
pathway by the retention of β-catenin at cellular junctions
(Wheelock and Johnson 2003). Upon entering the cell nucle-
us, β-catenin can function as a transcription factor and can
alter the expression of cyclin D-1 (Dejana 2004) and thus
promote endothelial cell proliferation (Venkiteswaran et al.
2002). Based on the observation that agrin mediates the junc-
tional stabilization of β-catenin, we have analyzed the prolif-
eration rate of bEnd5 cells in the presence and absence of
agrin. In accordance with these previous findings, we have
indeed observed decreased proliferation rates in bEnd5 cells
when cultured on exogenous agrin.
Interestingly, although the lack of agrin results in the im-
paired junctional localization of VE-cadherin, β-catenin, and
ZO-1 in pMBMECs, this phenotype does not have the im-
paired barrier characteristics of these cells in vitro. Similarly,
although brain microvessels in c-magB8//agrn
−/−mice show an
impaired junctional localization of VE-cadherin, a focal and
heterogeneous defect in BBB integrity has only been observed
in less than 30 % of these mice, suggesting that this might
instead be attributable to secondary effects in these mice
reconstituted for muscular agrin (Lin et al. 2008). This is
further supported by previous observations that mice lacking
vascular agrin do not develop a leaky BBB in vivo (Rauch
et al. 2011). In peripheral vascular beds, AJs have been shown
to play a prominent role in regulating vascular permeability,
e.g., by regulating the expression and junctional localization
of TJ proteins such as claudin-5 (Dejana et al. 2008; Taddei
et al. 2008). At the BBB, the expression levels of VE-cadherin
are, however, lower than those in peripheral vascular beds
(Breier et al. 1996), and conversely, the expression levels of
claudin-5 are much higher at the BBB than elsewhere and are
indeed critical for the establishment of the barrier functions of
CNS microvascular endothelial cells (Nitta et al. 2003). In this
context, it is therefore interesting to note that the stabilization
of junctional localization of claudin-5 in brain endothelial
cells has been reported to rely critically on matrix adhesions
of brain endothelial cells via their β1-integrins (Osada et al.
2011); this study has also demonstrated that matrix adhesions
at the basal side of brain endothelial cells can affect junctional
architecture and thus adhesive contacts at the lateral border
between brain endothelial cells. In combination with our
present observation that agrin fails to influence the junctional
localization of claudin-5, these data lead us to speculate that,
especially at the BBB, the reduced junctional localization of
VE-cadherin and thus the impaired AJ integrity in the absence
of agrin do not suffice to affect TJ integrity and hence com-
promise the barrier characteristics of the BBB in the absence
of additional pathological stimuli in vivo.
The agrin-induced increased junctional localization of AJ
proteins in brain endothelial cells is most probably attributable
to the aggregating characteristics of agrin. Neuronal agrin has
been shown to mediate the aggregation of AChR onmyotubes
(Gesemann et al. 1995), whereas both neuronal and non-
neuronal agrin can stabilize the accumulation of the water
channel protein aquaporin-4 to the membranes of astrocyte
foot processes (Noell et al. 2007). The ability of agrin to
aggregate membrane-associated molecules has been assigned
to its ability to concentrate molecules at specialized membrane
microdomains such as lipid rafts (Khan et al. 2001). VE-
cadherin and ZO-1 have previously been shown to localize
to raft-like membrane microdomains suggesting that these
microdomains contribute to the clustering of AJ and TJ pro-
teins. This has been further supported by the finding that the
knock-down of caveolin-1, a scaffolding protein associated
with lipid rafts, leads to the loss of VE-cadherin, β-catenin,
Table 1 Leakage of cerebral microvessels to exogenous and endogenous plasma tracersa in c-magB8//agrn
−/− mice depending on gender and age (BBB
blood-brain barrier)




with BBB leakage at <
6 weeks of age
Number of mice with
BBB leakage at 7–








3-kDa and 10-kDa Dextransa
3/23 0/2 3/21 3/11 0/12
Endogenous IgG (150–170 kDa)
and fibronectin (340 kDa)a
7/23 2b/2 5/21 4/11 3/12
a Leakage of tracers was determined by immunofluorescence staining and analysis of brain cryosections and was defined by the detection of the tracers
beyond the laminin-positive vascular basement membranes of brain microvessels
b Exclusive leakage of murine IgG
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and ZO-1 from these detergent-resistant membrane domains
(Nusrat et al. 2000; Song et al. 2007). We therefore asked
whether the culturing of bEnd5 cells in the presence of exog-
enous neuronal or non-neuronal agrin would trigger the forma-
tion of lipid rafts. By staining bEnd5 cells for the lipid raft
marker cholera toxin B (CTx-B) subunit that associates with
ganglioside GM1 (Schon and Freire 1989) and additionally for
caveolin-1, we could not provide any evidence for the agrin-
induced stabilization of VE-cadherin, β-catenin, and ZO-1 in
bEnd5 cell-cell junctions by the clustering of lipid rafts. How-
ever, we cannot exclude that the clustering of membrane mi-
crodomains is difficult to visualize in adherent cells.
In summary, the present study provides the first direct evi-
dence that, beyond its role as a key organizer of postsynaptic
differentiation, agrin, by providing matrix adhesions at the basal
side of brain endothelial cells, affects the junctional integrity of
endothelial AJs and thus contributes to BBB integrity.
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